Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludrocortisone for intradialytic hypotension
TCTR20200128004Phase 3Completed
- Sponsor
- Lampang Hospital
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fludrocortisone in intradialytic hypotension (IDH) (2 arms), sponsored by Lampang Hospital. Primary endpoints: Number of intradialytic hypotension events by KDOQI 2002 criteria and Change in intradialytic blood pressure. Started Mar 2020; status: completed.
02
Drugs
fludrocortisone
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on TCTR20200128004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200128004.